NDC 69097-878 – Bupropion Hydrochloride (sr)
Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Oral
Product NDC69097-878
Product details
- Brand name
- Bupropion Hydrochloride (sr)
- Generic name
- Bupropion Hydrochloride
- Labeler
- Cipla USA Inc.,
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA206674
- Marketed since
- July 25, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminoketone
Active ingredients
- Bupropion Hydrochloride 150 mg/1
Uses, dosage, side effects and warnings for Bupropion Hydrochloride (sr) →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 69097-878-02 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-02) | Jul 25, 2016 |
| 69097-878-03 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-03) | Jul 25, 2016 |
| 69097-878-07 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-07) | Jul 25, 2016 |
| 69097-878-12 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-12) | Jul 25, 2016 |
Recalls mentioning this NDC
- D-0618-2018 Apr 11, 2018 · Class III
Failed Dissolution Specifications; during stability testing - D-0619-2018 Apr 11, 2018 · Class III
Failed Dissolution Specifications; during stability testing
Other Bupropion Hydrochloride (sr) products
- 50090-5101 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 69097-877 Bupropion Hydrochloride 100 mg/1 · Tablet, Extended Release · Cipla USA Inc.,
- 69097-879 Bupropion Hydrochloride 200 mg/1 · Tablet, Extended Release · Cipla USA Inc.,
- 43598-863 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Dr. Reddy's Laboratories Inc
- 72189-349 Bupropion Hydrochloride 150 mg/1 · Tablet, Film Coated, Extended Release · DirectRx